146 related articles for article (PubMed ID: 34154795)
21. Treatment results in adult-onset recurrent respiratory papillomatosis.
Verguts MM; Genbrugge E; de Jong FI
B-ENT; 2009; 5(3):137-41. PubMed ID: 19902848
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Safety of Intralesional Cidofovir for Adjuvant Treatment of Recurrent Respiratory Papillomatosis.
Hoesli RC; Thatcher AL; Hogikyan ND; Kupfer RA
JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):231-236. PubMed ID: 31895450
[TBL] [Abstract][Full Text] [Related]
23. Intralesional cidofovir for pediatric recurrent respiratory papillomatosis.
Mandell DL; Arjmand EM; Kay DJ; Casselbrant ML; Rosen CA
Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1319-23. PubMed ID: 15545589
[TBL] [Abstract][Full Text] [Related]
24. Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children?
Peyton Shirley W; Wiatrak B
Int J Pediatr Otorhinolaryngol; 2004 Apr; 68(4):413-8. PubMed ID: 15013606
[TBL] [Abstract][Full Text] [Related]
25. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
[TBL] [Abstract][Full Text] [Related]
26. Voice improvement in patients with recurrent respiratory papillomatosis after combined treatment with cidofovir and CO
Jackowska J; Wojnowski W; Hashimoto A; Małaczyńska B; Piersiala K; Świdziński P; Wiskirska-Woźnica B; Wierzbicka M
Lasers Med Sci; 2019 Sep; 34(7):1433-1440. PubMed ID: 30762194
[TBL] [Abstract][Full Text] [Related]
27. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
Milczuk HA
Otolaryngol Head Neck Surg; 2003 Jun; 128(6):788-94. PubMed ID: 12825028
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of combined approach to recurrent respiratory papillomatosis (RRP).
Aga A; Bekteshi E; Ajasllari G; Kosta A; Vajushi E; Kortoci R; Filauro M; Muka T; Peretti G
Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3693-3700. PubMed ID: 38637412
[TBL] [Abstract][Full Text] [Related]
29. Systemic bevacizumab for treatment of recurrent respiratory papillomatosis.
Zhao X; Wang J; Chen Q; Wu X; Mao W; Ma J; Fang R; He P; Wei C
Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1865-1875. PubMed ID: 38180605
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
[TBL] [Abstract][Full Text] [Related]
31. Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
Clamp PJ; Saunders MW
Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):323-8. PubMed ID: 23369614
[TBL] [Abstract][Full Text] [Related]
32. Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir--a prospective study.
Dikkers FG
Eur Arch Otorhinolaryngol; 2006 May; 263(5):440-3. PubMed ID: 16328406
[TBL] [Abstract][Full Text] [Related]
33. Current diagnostic and management trends for recurrent respiratory papillomatosis.
Silverman DA; Pitman MJ
Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):532-7. PubMed ID: 15548913
[TBL] [Abstract][Full Text] [Related]
34. [The schedule of intralesional papillomatosis treatment with cidofovir].
Szyfter W; Wierzbicka M; Jackowska J; Bartochowska A; Banaszewski J
Otolaryngol Pol; 2010; 64(2):98-102. PubMed ID: 20568538
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy for recurrent respiratory papillomatosis (RRP): a treatment update.
Donne AJ; Kinshuck A
Expert Opin Pharmacother; 2021 Oct; 22(14):1901-1908. PubMed ID: 34080517
[No Abstract] [Full Text] [Related]
36. High-dose sublesional bevacizumab (avastin) for pediatric recurrent respiratory papillomatosis.
Sidell DR; Nassar M; Cotton RT; Zeitels SM; de Alarcon A
Ann Otol Rhinol Laryngol; 2014 Mar; 123(3):214-21. PubMed ID: 24633948
[TBL] [Abstract][Full Text] [Related]
37. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.
Broekema FI; Dikkers FG
Eur Arch Otorhinolaryngol; 2008 Aug; 265(8):871-9. PubMed ID: 18458927
[TBL] [Abstract][Full Text] [Related]
38. Follow-up of HPV DNA copy number in cidofovir therapy of recurrent respiratory papillomatosis.
Major T; Sziklai I; Czeglédy J; Gáll T; Gergely L; Szarka K
Anticancer Res; 2008; 28(4B):2169-74. PubMed ID: 18751391
[TBL] [Abstract][Full Text] [Related]
39. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
40. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis.
Pransky SM; Brewster DF; Magit AE; Kearns DB
Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1239-43. PubMed ID: 11031411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
